Stephen J. McAndrew

Stephen J. McAndrew, Ph.D. has a strong background in business development and strategic leadership in the biopharmaceutical industry. Stephen J. has served as Vice President and Senior Vice President in various companies, including Sonnet BioTherapeutics, Inc. and Oncobiologics, Inc. In these roles, they developed revenue generation strategies, executed partnership deals, and managed partner relationships. Dr. McAndrew also has experience in portfolio and IP management, investment strategy, and funding sourcing. Prior to their executive roles, they worked as a Biopharmaceutical Consultant and held management positions in companies such as Taconic Biosciences, Caliper Life Sciences, Xenogen Corporation, and Bristol-Myers Squibb. Stephen J. holds a Ph.D. and has a strong scientific background in molecular immunology.

Stephen J. McAndrew, Ph.D. earned a Ph.D. in Molecular & Cellular Biology from Ohio University, from 1986 to 1990. Prior to that, they obtained an MS degree in Yeast Genetics from the University at Albany, SUNY, between 1978 and 1980. Stephen J. also completed their undergraduate education, earning a BS in Biology/Zoology from the State University of New York at Oswego, from 1974 to 1976.